Operations & SupplyEvent: September 4, 2026
LambdaVision, Inc. is evaluating its protein on an orbital platform for its mission with Helogen Corporation in October.
Published
Signal category
Operations & Supply
Quote
“Our mission with Helogen Corporation will give us the opportunity to evaluate our protein on an orbital platform and build on what we’ve learned through our ISS research”
— Nicole Wagner, Ph.D.|LambdaVision, Inc. team
Company
LambdaVision, Inc.
Leveraging Space to Restore Vision with a Protein-Based Artificial Retina
- Industry
- Biotechnology
- Location
- Woodbridge, US
- Company size
- 13 employees
LambdaVision is leveraging space to develop a protein-based artificial retina to restore meaningful vision for the millions of patients blinded by retinal degenerative diseases. View our Community Guidelines: https://bit.ly/LambdaVisionCGs
Founded 2018